ArticleFrontiers in oncology2025

Dosimetric advantages of dual-layer MLC in hypofractionated stereotactic radiotherapy for multiple brain metastases: a comparative study with single-layer MLC.

Changyou Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.